Cascaded Nanozyme with In Situ Enhanced Photothermal Capacity for Tumor‐Specific and Self‐Replenishing Cancer Therapy
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202300516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Xiaoli Cai und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensing Technology and Health, College of Chemistr…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Wuhan University of Science and Technology, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Reactive oxygen species (ROS)‐involved tumor therapeutic strategy, chemodynamic therapy (CDT), has attracted extensive research interest in the scientific community. However, the therapeutic effect of CDT is insufficient and unsustainable owing to the limited endogenous H 2 O 2 level in the tumor microenvironment. Here, peroxidase (POD)‐like RuTe 2 nanozyme with the immobilization of glucose oxidase (GOx) and allochroic 3,3′,5,5′‐tetramethylbenzidine (TMB) molecule have been synthesized to construct RuTe 2 ‐GOx‐TMB nanoreactors (RGT NRs) as cascade reaction systems for tumor‐specific and self‐replenishing cancer therapy. GOx in sequential nanocatalysts can effectively deplete glucose in tumor cells. Meanwhile, a sustainable supply of H 2 O 2 for subsequent Fenton‐like reactions catalyzed by RuTe 2 nanozyme is achieved in response to the mild acidic tumor microenvironment. Through this cascade reaction, highly toxic hydroxyl radicals (·OH) are produced, which can further oxidize TMB to trigger tumor‐specific “turn‐on” photothermal therapy (PTT). In addition, PTT and massive ROS can stimulate the tumor immune microenvironment and activate the systematic anti‐tumor immune responses, exerting a notable effect on hindering tumor recurrence and metastasis. This study paves a promising paradigm for synergistic starvation therapy, PTT, and CDT cancer therapy with high efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensing Technology and Health, College of Chemistry, Central China Normal University, Wuhan, 430079, China.
- Academy of Nutrition and Health, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Public Health, Wuhan University of Science and Technology, Wuhan, 430065, China.
- Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, China.
- College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China.
ORCID-Profile: Chengzhou Zhu
Förderung
- Wuhan University of Science and Technology
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Cai, X., Liu, R., Yan, H., Jiao, L., Sha, M., Chen, Y., Rong, S., Liu, Z., Deng, L., Shen, L., & Zhu, C. (2023). Cascaded Nanozyme with In Situ Enhanced Photothermal Capacity for Tumor‐Specific and Self‐Replenishing Cancer Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300516
Vancouver
Cai X, Liu R, Yan H, Jiao L, Sha M, Chen Y, et al. Cascaded Nanozyme with In Situ Enhanced Photothermal Capacity for Tumor‐Specific and Self‐Replenishing Cancer Therapy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300516
BibTeX
@article{Cai2023,
author = {Cai, Xiaoli and Liu, Renyu and Yan, Hongye and Jiao, Lei and Sha, Meng and Chen, Yifeng and Rong, Shuang and Liu, Zhengzheng and Deng, Liu and Shen, Liangfang and Zhu, Chengzhou},
title = {Cascaded Nanozyme with In Situ Enhanced Photothermal Capacity for Tumor‐Specific and Self‐Replenishing Cancer Therapy},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202300516}
}
EUVIMED